Denmark’s Novo Nordisk faces diminished profits and price-fixing lawsuit in US

Denmark’s Novo Nordisk faces diminished profits and price-fixing lawsuit in US

Denmark's Novo Nordisk, the world's top insulin maker, said on Thursday its 2016 net profit was below forecasts due to falling product prices in the US, a huge market for the company.

Novo Nordisk to cut 500 jobs in Denmark, 1,000 overall

Novo Nordisk to cut 500 jobs in Denmark, 1,000 overall

‘World’s best CEO’ to retire from Novo Nordisk

‘World’s best CEO’ to retire from Novo Nordisk

Denmark’s Novo Nordisk cuts forecasts on price fears

Denmark’s Novo Nordisk cuts forecasts on price fears

Denmark’s Novo Nordisk says US launch ‘encouraging’

Denmark’s Novo Nordisk says US launch ‘encouraging’

Novo Nordisk to build new facility in Iran

Novo Nordisk to build new facility in Iran

placeholder image

Novo profit boosted by North American growth